Revenue - Allergy Therapeutics PLC (LSE:AGY) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 2.875 GBX

Updated:

Allergy Therapeutics PLC
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Allergy Therapeutics PLC
Revenue Peer Comparison

GSK

AZN

INDV

HIK

DPH

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Allergy Therapeutics PLC LSE:AGY	Revenue £53.3m	CAGR 3-Years -13%	CAGR 5-Years -6%	CAGR 10-Years 3%
	GlaxoSmithKline PLC LSE:GSK	Revenue £30.3B	CAGR 3-Years 8%	CAGR 5-Years 0%	CAGR 10-Years 2%
	AstraZeneca PLC LSE:AZN	Revenue $45.8B	CAGR 3-Years 20%	CAGR 5-Years 16%	CAGR 10-Years 6%
	Indivior PLC LSE:INDV	Revenue $1.1B	CAGR 3-Years 19%	CAGR 5-Years 2%	CAGR 10-Years N/A
	Hikma Pharmaceuticals PLC LSE:HIK	Revenue $2.9B	CAGR 3-Years 7%	CAGR 5-Years 7%	CAGR 10-Years 8%
	Dechra Pharmaceuticals PLC LSE:DPH	Revenue £761.5m	CAGR 3-Years 14%	CAGR 5-Years 13%	CAGR 10-Years 15%

See Also

Based on the financial report for Dec 31, 2023, Allergy Therapeutics PLC's Revenue amounts to 53.3m GBP.

Over the last year, the Revenue growth was -17%. The average annual Revenue growth rates for Allergy Therapeutics PLC have been -13% over the past three years , -6% over the past five years , and 3% over the past ten years .

Join more than 134,000+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.